IDiyas

For the Inventor, By the Inventor

Berlin, Germany

Olaf Loge

USPTO Granted Patents = 40

Average Co-Inventor Count = 5.4

ph-index = 13

Forward Citations = 395(Granted Patents)


Company Filing History:

goldMedal40 out of 1,384 
 
Schering Aktiengesellschaft
 patents

Years Active: 1976-2001

Loading Chart...
40 patents (USPTO):Explore Patents
1. 6225347 - 9-halogen-(Z)-prostaglandin derivatives, process for their production and their use as pharmaceutical agents (2001-05-01),
2. 5891910 - 9-halogen-(Z) prostaglandin derivatives, process for their production (1999-04-06),
3. 5204371 - Pharmaceutically active 9-chloroprostaglandins (1993-04-20),
4. 5079259 - Pharmaceutically active 9-chloroprostaglandins (1992-01-07),
5. 5049582 - Prostacyclin derivatives with cytoprotective effect on liver, pancreas (1991-09-17),
6. 5047525 - 9-haloprostaglandin clathrates and their use as medicines (1991-09-10),
7. 5010065 - Cyclodextrin clathrates of 5-cyanoprostacyclin derivatives and their use (1991-04-23),
8. 5004752 - Novel 9-haloprostaglandins, processes for their preparation, and their (1991-04-02),
9. 4983629 - 11-haloprostane derivatives, processes for their preparation and their (1991-01-08),
10. 4894391 - Novel prostacyclin derivatives, process for the preparation thereof, and (1990-01-16),
11. 4870104 - 11-haloprostane derivatives, processes for their preparation and their (1989-09-26),
12. 4835175 - Indole derivatives pharmaceutical preparations based thereon, and (1989-05-30),
13. 4789685 - 9-fluoroprostaglandin derivatives, their preparation and use as (1988-12-06),
14. 4721729 - Novel carbacyclins, process for the preparation thereof, and their use (1988-01-26),
15. 4699920 - 9-halo-2-prostaglandin derivatives, processes for the preparation (1987-10-13),

Title: **Olaf Loge: Pioneer in Pharmaceutical Innovations from Berlin**

Introduction

Olaf Loge, a renowned inventor based in Berlin, Germany, has made significant contributions to the field of pharmaceuticals, holding an impressive portfolio of 40 patents. His innovations focus primarily on novel prostaglandin derivatives, showcasing his commitment to advancing medical science through cutting-edge research and development.

Latest Patents

Among Olaf's latest patents are the inventions relating to 9-halogen-(Z)-prostaglandin derivatives, including a detailed process for their production and their application as pharmaceutical agents. The inventions specifically pertain to 9-halogen-(Z) prostane derivatives with the unique formula that incorporates halogen elements such as chlorine or fluorine atoms. These advancements hold promise for developing effective new treatments in pharmaceuticals.

Career Highlights

Olaf Loge has built a remarkable career at Schering Aktiengesellschaft, a company recognized for its emphasis on research and development in the pharmaceutical domain. His significant contributions, underscored by the number of patents filed, demonstrate his influence and expertise in creating innovative solutions to pressing medical challenges.

Collaborations

Throughout his career, Olaf has collaborated with notable colleagues, including Werner Skuballa and Walter Elger. Together, they have worked on various projects that leverage their combined expertise in creating groundbreaking pharmaceutical products.

Conclusion

Olaf Loge stands out as a leading figure in pharmaceutical innovation, with numerous patents reflecting his dedication to improving healthcare. His work continues to inspire the next generation of inventors and scientists, and his contributions to the field will undoubtedly leave a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…